Harris Technology Group Limited reported $3.6 million in sales and a positive operating cash flow in Q2 FY25, driven by strong performance in refurbished technology products as the company adjusts its inventory strategy.
Michael Hill International reports a 24% drop in comparable EBIT for FY25H1 amid challenging conditions, yet margin improvements and digital growth offer a silver lining.
LTR Pharma has inked a national distribution agreement with Symbion, positioning its innovative ED treatment SPONTAN® for broad pharmacy access across Australia ahead of its commercial launch.